Addressing Reproducibility in Stem Cell and PRP Therapies
- PMID: 30579716
- DOI: 10.1016/j.tibtech.2018.11.010
Addressing Reproducibility in Stem Cell and PRP Therapies
Abstract
Stem cell and platelet-rich plasma (PRP) therapies are promising breakthroughs in the treatment of multiple conditions. However, the lack of reproducibility due to inaccurate reporting of the protocols used to obtain these biologics can hinder their therapeutic progress. A reporting guideline for biological therapies is required to address this issue.
Keywords: CONSORT; EQUATOR; biological therapies; platelet-rich plasma; reporting guidelines; stem cell.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials